207748-29-6
207748-29-6
Chemical Structure
Insulin glulisine
Synonym(s): HMR 1964
- CAS No.: 207748-29-6
- Formula:C258H384N64O78S6
- Molecular Weight:5822.57
SMILES: [Insulin glulisine]
Biological Activity: Insulin glulisine (HMR 1964) is a rapid-acting insulin analog whose pharmacokinetic and pharmacodynamic properties mimic physiological insulin secretion in humans, with a rapid onset of action. Insulin glulisine controls hyperglycemia. Insulin glulisine is applicable to research related to type 1 diabetes and type 2 diabetes[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Insulin glulisine | 95.0% | Insulin glulisine (HMR 1964) is a rapid-acting insulin analog whose pharmacokinetic and pharmacodynamic properties mimic physiological insulin secretion in humans, with a rapid onset of action. Insulin glulisine controls hyperglycemia. Insulin glulisine is applicable to research related to type 1 diabetes and type 2 diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Insulin glulisine (Standard) | ≥98% | Insulin glulisine (Standard) is the analytical standard of Insulin glulisine (HY-109555). This product is intended for research and analytical applications. Insulin glulisine (HMR 1964) is a rapid-acting insulin analogue, it mimics the pharmacoKinetic and pharmacodynamic profiles of physiological human insulin. Insulin glulisine can be used for the research of diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
